Buy Butylone (bk-MBDB) Online

Buy Butylone (Bk-MBDB) Online,Firstly,talking about Butylone, also know as β-keto-N-methylbenzodioxolylbutanamine is an entactogen, psychedelic, and stimulant psychoactive drug of the phenethylamine chemical class.Buy Butylone (Bk-MBDB) Online

Secondly, the most common metabolite is the 4-OH-3-MeO metabolite.Buy Butylone (Bk-MBDB) Online The metabolites containing a hydroxyl-group would be excrete as their conjugates in urine

Buy Butylone (Bk-MBDB) Online

Still,Butylone can be acquire  online at drharrisonclinic.com and has a full IUPAC name of 1-(1,3-benzodioxol-5-yl)-2-(methylamino)-1-butanone, monohydrochloride which belongs to a class of research chemicals called central nervous system stimulants.

Again,there are three major metabolic pathways of bk-MBDB as shown in the figure.Butylone (Bk-MBDB, Furthermore,as result of demethylenation followed by O-methylation bk-MBDB metabolises into 4-OH-3-MeO and 3-OH-4-MeO metabolites in human urine. The second pathway is a β-ketone reduction into β-ketone reduce metabolites. The third pathway is a N-dealkylation into N-dealkylmetabolites.

Butylone acts in a similar way as MDMA and Methylone, it causes an increase in extracellular monoamine levels Butylone was first synthesize by Koeppe, Ludwig and Zeile which is mention in their 1967 paper. It remain an obscure product of academia until 2005 when it was acquire as a designer drug,Butylone shares the same relationship to MBDB as methylone does to MDMA (“Ecstasy”). Formal research on this chemical was first conducted in 2009, when it was shown to be metabolised in a similar manner to related drugs like methylone Butylone, also known as β-keto-N-methylbenzodioxolylbutanamine (βk-MBDB), is an entactogen, psychedelic, and stimulant psychoactive drug of the phenethylamine chemical class. It is the β-keto (substitute cathinone) analogue of MBDB and the substitute methylenedioxyphenethylamine analogue of buphedrone

There are three major metabolic pathways of bk-MBDB as shown in the figure. As result of demethylenation followed by O-methylation bk-MBDB metabolises into 4-OH-3-MeO and 3-OH-4-MeO metabolites in human urine. The second pathway is a β-ketone reduction into β-ketone reduce metabolites. The third pathway is a N-dealkylation into N-dealkyl metabolites. The first two pathways occur more than pathway three. Lastly,The most common metabolite is the 4-OH-3-MeO metabolite. The metabolites containing a hydroxyl-group would be excreted as their conjugates in urine